Congress affirms that regulations account for over 80% of drug development time

posted by
January 16, 2011
Liberty For All
by Mary J. Ruwart  
Posted in Commentary

"As a consequence of the increasing development times, new drugs often enter the marketplace with only a few years of patent life remaining. Consequently, manufacturers had to charge excessive prices for new drugs in order to make up their increasing research and development costs. To counter this trend, Congress passed the Waxman-Hatch Patent Restoration Act in 1984 to extend pharmaceutical patent life." (01/16/11)  

Our Sponsors